Flicker sensitivity change predicts development of GA

Article

The rate of change in flicker sensitivities is helpful in predicting geographic atrophy (GA)

The rate of change in flicker sensitivities is helpful in predicting geographic atrophy (GA), according to a study in the Archives of Ophthalmology.

The longitudinal investigation, led by Dr D. Luu, Centre for Eye Research Australia, University of Melbourne, Australia, looked at 187 patients with early age-related macular degeneration (AMD).

Patients completed a minimum of four consecutive 6-monthly flicker perimetry tests. The study groups included 16 people who developed GA, 24 controls and 18 high-risk early-AMD patients.

The results revealed that compared to the control group, mean flicker sensitivity reduced in the months before the patients developed GA or choroidal neovascularization (CNV).

Rate of change in flicker sensitivity significantly increased in GA patients, but not in patients with CNV. Eyes that developed late AMD experienced a large reduction in flicker sensitivity.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.